Protara TherapeuticTARA
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 38 institutions reported holding Protara Therapeutic Inc. (TARA) in their 13F filings, up 4 from Q1 2024. 11 opened new positions and 7 sold out. The largest holders were Opaleye Management Inc. ($5.3M), Ra Capital Management, L.P. ($4.0M) and Stempoint Capital LP ($2.0M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Protara Therapeutic Inc.
- CUSIP
- 74365U107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $7.2M |
| Exits | 7 | $237K |
All 13F filers, Q1 2024 → Q2 2024: 6,392,405 shares bought and 513,248 shares sold, net +5,879,157 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| Opaleye Management Inc. | 1.23% | Reduce -14.4% | 2,304,262 | $5.3M |
| Ra Capital Management, L.P. | 0.05% | New | 1,900,000 | $4.0M |
| Stempoint Capital LP | 0.60% | Add +484.2% | 984,113 | $2.0M |
| Boxer Capital, LLC | 0.09% | Add +287.9% | 811,627 | $1.7M |
| Citadel Advisors | 0.00% | Add +2464.3% | 665,372 | $1.4M |
| Baker Bros. Advisors LP | 0.01% | Add +168.9% | 536,832 | $1.1M |
| Armistice Capital, LLC | 0.03% | New | 520,000 | $1.1M |
| Velan Capital Investment Management LP | 0.57% | New | 480,000 | $998K |
| Vanguard Group Inc. | 0.00% | No change | 427,612 | $889K |
| CVI Holdings, LLC | 0.59% | New | 302,746 | $630K |
| Ikarian Capital, LLC | 0.12% | Reduce -10.8% | 180,712 | $376K |
| Two Sigma Investments, LP | 0.00% | Add +688.8% | 155,773 | $324K |
| Renaissance Technologies | 0.00% | Add +77.8% | 150,400 | $313K |
| Geode Capital Management, LLC | 0.00% | Add +69.5% | 140,526 | $292K |
| Oppenheimer & Co. Inc. | 0.00% | Add +1171.8% | 127,181 | $265K |
| BlackRock Inc. | 0.00% | Add +273.5% | 115,273 | $240K |
| Privium Fund Management (UK) Ltd | 0.09% | Reduce -4.2% | 114,708 | $233K |
| Woodline Partners LP | 0.00% | New | 100,001 | $208K |
| Two Sigma Advisers, LP | 0.00% | Add +198.0% | 80,518 | $167K |
| Marshall Wace, LLP | 0.00% | New | 77,351 | $161K |
| LPL Financial LLC | 0.00% | Add +57.1% | 44,000 | $92K |
| Cibc World Market Inc. | 0.00% | New | 37,000 | $77K |
| Northern Trust Corp. | 0.00% | Add +64.7% | 28,976 | $60K |
| State Street Corp. | 0.00% | No change | 26,600 | $55K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -59.0% | 24,200 | $50K |
| Boothbay Fund Management, LLC | 0.00% | Reduce -10.8% | 20,191 | $42K |
| Truist Financial Corp. | 0.00% | No change | 20,000 | $42K |
| Commonwealth Equity Services, LLC | 0.00% | New | 19,428 | $40K |
| Bank of New York Mellon Corp | 0.00% | No change | 17,907 | $37K |
| Jane Street Group, LLC | 0.00% | New | 12,850 | $27K |
| Susquehanna International Group, LLP | 0.00% | Reduce -10.3% | 10,036 | $21K |
| Royal Bank of Canada | 0.00% | Add +58.1% | 6,302 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +55.8% | 4,019 | $8K |
| Group One Trading LLC | 0.00% | New | 2,550 | $5K |
| Wells Fargo & Company | 0.00% | Reduce -12.3% | 500 | $1K |
| Bank of America Corp. | 0.00% | New | 149 | $310 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $208 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $4 |
"% of holder's portfolio" is TARA's weight in each manager's 13F, not the share of Protara Therapeutic Inc. the manager owns.